|
Patient Insight Mar 19: What They’re Reading
|
This week, Allure deep-dives into eyelid ptosis, the myth of “black don’t crack,” and the world of at-home products that offer noninvasive “nose jobs” perpetuated today by social media is examined in Wired.
|
|
|
Soliton recently announced that the FDA has given their Generation II RAP device special 510(k) premarket notification clearance as an adjunct to lasers for tattoo removal, with a planned commercial launch in mid-2020.
While clinical data support certain oral and topical pre-, pro- and postbiotic products for some dermatologic conditions, Dr. Anna Chacon examines potential applications in the aesthetic specialty.
Where does COVID-19 leave the cosmetic medical practice? According to Dr. Jonathan Kaplan, it’s important to stay in contact with patients via technology like virtual consults and implement procedures to keep both physicians and patients safe.